47 related articles for article (PubMed ID: 11037802)
41. Metabolic enzyme polymorphisms and susceptibility to acute leukemia in adults.
Morgan GJ; Smith MT
Am J Pharmacogenomics; 2002; 2(2):79-92. PubMed ID: 12083944
[TBL] [Abstract][Full Text] [Related]
42. Acute myeloid leukaemia at an early age: Reviewing the interaction between pesticide exposure and
Pombo-de-Oliveira MS; Andrade FG; Brisson GD; Dos Santos Bueno FV; Cezar IS; Noronha EP
Ecancermedicalscience; 2017; 11():782. PubMed ID: 29225689
[TBL] [Abstract][Full Text] [Related]
43. Poor metabolizers at the cytochrome P450 2D6 and 2C19 loci are at increased risk of developing adult acute leukaemia.
Roddam PL; Rollinson S; Kane E; Roman E; Moorman A; Cartwright R; Morgan GJ
Pharmacogenetics; 2000 Oct; 10(7):605-15. PubMed ID: 11037802
[TBL] [Abstract][Full Text] [Related]
44. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
de Leon J; Susce MT; Murray-Carmichael E
Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
[TBL] [Abstract][Full Text] [Related]
45. Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.
de Leon J; Armstrong SC; Cozza KL
Psychosomatics; 2006; 47(1):75-85. PubMed ID: 16384813
[TBL] [Abstract][Full Text] [Related]
46. Pharmacogenetics and psychopharmacotherapy.
Poolsup N; Li Wan Po A; Knight TL
J Clin Pharm Ther; 2000 Jun; 25(3):197-220. PubMed ID: 10886465
[TBL] [Abstract][Full Text] [Related]
47. Interethnic differences of drug-metabolizing enzymes.
Gaedigk A
Int J Clin Pharmacol Ther; 2000 Feb; 38(2):61-8. PubMed ID: 10706192
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
